A. Iop

Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

Francesco Di Costanzo, Paolo Carlini, Laura Doni et al. · British Journal of Cancer · 2005 · 99 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +10

Oxaliplatin in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV) in Patients With Metastatic Gastric Cancer (MGC)

Luigi Cavanna, Fabrizio Artioli, Claudio Codignola et al. · American Journal of Clinical Oncology · 2006 · 62 citations

Medicine, Oncology, Pharmacology +14

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

Emilio Bajetta, Maria Di Bartolomeo, Roberto Buzzoni et al. · British Journal of Cancer · 2007 · 38 citations · Full text

Medicine, Oncology, Pharmacology +15

The expression of the high-mobility group A2 protein in colorectal cancer and surrounding fibroblasts is linked to tumor invasiveness

Claudio Rizzi, Palmina Cataldi, A. Iop et al. · Human Pathology · 2012 · 26 citations

Medicine, Molecular Biology, Oncology +14